Fonterra Valuation Multiples

Discover Fonterra's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Emmi, AAK, Gruma, Glanbia and more.

Fonterra Overview

About Fonterra

Fonterra Co-operative Group Ltd operates predominantly in the international dairy industry. The company is involved in the collection, manufacture, and sale of milk and milk-derived products through its ingredients, Consumer and Foodservice channels. The company's reportable segments are Global Markets, Greater China, and Core Operations and the majority of the revenue is generated from its core operations segment. Its primary geographic markets is Asia, China, Australia, New Zealand, the United States, and the Rest of the world.


Founded

2001

HQ

New Zealand

Employees

15.7K

Financials (LTM)

Revenue: $14B
EBITDA: $1.3B

EV

$9B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Fonterra Financials

Fonterra reported last 12-month revenue of $14B and EBITDA of $1.3B.

In the same LTM period, Fonterra generated $1.3B in EBITDA and $630M in net income.

Revenue (LTM)


Fonterra P&L

In the most recent fiscal year, Fonterra reported revenue of $15B and EBITDA of $1.4B.

Fonterra is profitable as of last fiscal year, with gross margin of 13%, EBITDA margin of 9%, and net margin of 4%.

See analyst estimates for Fonterra
LTMLast FY202320242025202620272028
Revenue$14B$15B$14B$14B$14B
Gross Profit-$1.9B$2.4B$2.1B$1.9B
Gross Margin-13%17%15%14%
EBITDA$1.3B$1.4B$1.4B$1.3B$1.3B
EBITDA Margin9%9%10%10%9%
EBIT Margin7%7%8%7%7%
Net Profit$630M$631M$813M$647M$631M
Net Margin5%4%6%5%5%

Financial data powered by Morningstar, Inc.

Fonterra Stock Performance

Fonterra has current market cap of $6B, and enterprise value of $9B.

Market Cap Evolution


Fonterra's stock price is $2.47.

Fonterra share price increased by 1.8% in the last 30 days, and decreased by 11.7% in the last year.

Fonterra has an EPS (earnings per share) of $0.26.

See more trading valuation data for Fonterra
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9B$6B0.1%1.8%-6.9%-11.7%$0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Fonterra Valuation Multiples

Fonterra trades at 0.7x EV/Revenue multiple, and 7.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Fonterra

EV / Revenue (LTM)


Fonterra Financial Valuation Multiples

As of July 19, 2026, Fonterra has market cap of $6B and EV of $9B.

Fonterra has a P/E ratio of 9.4x.

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.6x0.6x0.7x0.6x
EV/EBITDA7.0x6.3x6.5x6.9x7.0x
EV/EBIT9.2x8.5x8.4x9.8x9.6x
EV/Gross Profit-4.7x3.8x4.3x4.7x
P/E9.4x9.4x7.3x9.2x9.4x
EV/FCF-12.2x7.1x10.3x12.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Fonterra Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Fonterra Margins & Growth Rates

Fonterra decreased revenue by 10% and EBITDA by 10% in the last fiscal year.

In the most recent fiscal year, Fonterra reported gross margin of 13%, EBITDA margin of 9%, and net margin of 4%.

See estimated margins and future growth rates for Fonterra

Fonterra Margins

Last FY202420252026202720282029
Gross Margin13%15%14%-
EBITDA Margin9%10%9%9%
EBIT Margin7%7%7%7%
Net Margin4%5%5%5%
FCF Margin5%6%5%-

Fonterra Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(10%)(2%)2%(1%)
Gross Profit Growth-(11%)(9%)-
EBITDA Growth(10%)(6%)(1%)(0%)
EBIT Growth(8%)(14%)2%4%
Net Profit Growth0%(20%)(3%)0%
FCF Growth-(31%)(16%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Fonterra Operational KPIs

Fonterra's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.1M for the same period.

Fonterra's Rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Fonterra's Rule of X is 6% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Fonterra
LTMLast FY202320242025202620272028
Rule of 409%8%---
Bessemer Rule of X8%6%---
Revenue per Employee-$1.0M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-1%2%2%1%
G&A Expenses to Revenue-1%1%1%1%
Opex to Revenue-7%9%9%7%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Fonterra Competitors

Fonterra competitors include Emmi, AAK, Gruma, Glanbia, Meiji Group, Lamb Weston, Ingredion, Toyo Suisan, Nestlé Malaysia and Sam Yang Foods.

Most Fonterra public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Emmi1.1x1.2x11.0x11.1x
AAK1.2x1.2x9.7x9.8x
Gruma1.1x1.1x6.0x6.1x
Glanbia1.7x1.7x12.9x13.4x
Meiji Group0.9x0.9x7.1x7.0x
Lamb Weston1.6x1.6x8.5x9.4x
Ingredion1.0x1.0x5.9x6.1x
Toyo Suisan1.4x1.4x7.0x7.5x

This data is available for Pro users. Sign up to see all Fonterra competitors and their valuation data.

Start Free Trial

Investments by Fonterra

Fonterra has invested in 11 companies to date.

Latest investment by Fonterra was on February 25th 2025. Fonterra invested in Vivici in their $34M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Fonterra

Vivici
DNAiTECH
Metrovate
Jooules
Description
Vivici is a Netherlands-headquartered biotech company producing animal-free dairy proteins like whey and casein using precision fermentation. It supplies these sustainable ingredients to food manufacturers for ice cream, beverages, and baked goods. Backed by Big Idea Ventures, Vivici partners with DSM for commercialization, targeting the $14 billion whey market with proteins identical to bovine-derived versions.
DNAiTECH is a Ghent-based biotechnology firm developing point-of-care molecular diagnostics meeting WHO ASSURED criteria. The company produces the Beaker platform for rapid pathogen detection using isothermal amplification, targeting infectious diseases like tuberculosis and COVID-19. Founded in 2015, DNAiTECH collaborates with ECDC and deploys systems in low-resource settings across Africa and Asia. Its cartridge-based tests deliver results in under 30 minutes without lab infrastructure.
Metrovate is a biotechnology firm advancing global health and sustainability through research and development of novel therapies. The company targets microbiome-based interventions and precision medicine approaches to address chronic diseases and environmental health challenges.
Jooules is a Paris-headquartered biotechnology firm that produces nutritious protein ingredients via precision fermentation of carbohydrates. Founded in 2021, the company addresses sustainable food production by providing plant-derived proteins for food manufacturers and agribusinesses aiming to reduce reliance on animal agriculture.
HQ CountryNetherlandsUnited StatesNew ZealandNew Zealand
HQ City
Delft
Boston, MA
Auckland
Wellington
Deal Date25 Feb 202521 Oct 202414 May 20241 May 2024
RoundSeries APre-seedSeedSeed
Raised$34M$100K$600K$600K
InvestorsAPG Asset Management; Fonterra; Invest-NL; InnovationQuarter; DSM VenturingOurCrowd; Fonterra; Sprout; Finistere VenturesCallaghan Innovation; OurCrowd; Fonterra; Sprout; Finistere VenturesCallaghan Innovation; OurCrowd; Fonterra; Sprout; Finistere Ventures
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Fonterra investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Fonterra

When was Fonterra founded?Fonterra was founded in 2001.
Where is Fonterra headquartered?Fonterra is headquartered in New Zealand.
How many employees does Fonterra have?As of today, Fonterra has over 15K employees.
Is Fonterra publicly listed?Yes, Fonterra is a public company listed on New Zealand Exchange.
What is the stock symbol of Fonterra?Fonterra trades under FCG ticker.
When did Fonterra go public?Fonterra went public in 2012.
Who are competitors of Fonterra?Fonterra main competitors include Emmi, AAK, Gruma, Glanbia, Meiji Group, Lamb Weston, Ingredion, Toyo Suisan, Nestlé Malaysia, Sam Yang Foods.
What is the current market cap of Fonterra?Fonterra's current market cap is $6B.
What is the current revenue of Fonterra?Fonterra's last 12 months revenue is $14B.
What is the current revenue growth of Fonterra?Fonterra revenue growth (NTM/LTM) is (1%).
What is the current EV/Revenue multiple of Fonterra?Current revenue multiple of Fonterra is 0.7x.
What is the current EBITDA of Fonterra?Fonterra's last 12 months EBITDA is $1.3B.
What is Fonterra's EBITDA margin?Fonterra's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Fonterra?Current EBITDA multiple of Fonterra is 7.0x.
How many companies Fonterra has acquired to date?Fonterra hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Fonterra has invested to date?As of July 2026, Fonterra has invested in 11 companies.

See public comps similar to Fonterra

Lists including Fonterra

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial